Company news
Pacira BioSciences, Inc. news in 2022
Pacira BioSciences, Inc.'s news releases, calls and decks from 2022, newest first.
Pacira BioSciences Reports Preliminary Net Product Sales of $57.5 Million for November 2022
December 12, 2022
Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2022
November 13, 2022
Pacira BioSciences to Present at Two Healthcare Conferences in November
November 7, 2022
Pacira BioSciences Reports Third Quarter 2022 Financial Results
November 2, 2022
Pacira to Report Third Quarter 2022 Financial Results on Thursday November 3, 2022
October 19, 2022
Pacira BioSciences Reports Preliminary Third Quarter 2022 Revenue of $167.5 Million
October 12, 2022
Sevāredent Sourcing Solutions and Pacira BioSciences Collaborate to Provide Expanded Access to EXPAREL for Patients Undergoing Oral and Maxillofacial Procedures
September 26, 2022
Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Sciatic Nerve Block in the Popliteal Fossa for Bunionectomy
September 20, 2022
Pacira Receives Positive CHMP Opinion for EXPAREL® for the Treatment of Postsurgical Pain in Children Aged 6 or Older
September 19, 2022
Pacira BioSciences Reports Preliminary Net Product Sales of $59.1 Million for August 2022
September 12, 2022
Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Femoral Nerve Block in the Adductor Canal for Total Knee Arthroplasty
September 6, 2022
Pacira BioSciences Reports Preliminary Net Product Sales of $50.2 Million for July 2022
August 9, 2022
NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communities About Non-Opioid Options to Manage Pain
August 8, 2022
Pacira BioSciences Reports Second Quarter 2022 Financial Results
August 2, 2022
Pacira BioSciences to Participate in Fireside Chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference
August 1, 2022
Pacira to Report Second Quarter 2022 Financial Results on Wednesday August 3, 2022
July 26, 2022
Pacira BioSciences Reports Preliminary Second Quarter 2022 Revenue of $169.4 Million
July 13, 2022
National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Program Focused on Opioid Use and Misuse
June 15, 2022
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $46.0 Million for May 2022
June 13, 2022
Pacira BioSciences to Participate in Fireside Chat at the Jefferies Healthcare Conference
June 1, 2022
Pacira BioSciences and the National Senior Games Association Break a GUINNESS WORLD RECORDS™ Title for the Largest Game of Freeze Dance
May 24, 2022
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $45.8 Million for April 2022
May 11, 2022
Pacira BioSciences to Present at Two Healthcare Conferences in May
May 9, 2022
Pacira BioSciences Reports First Quarter 2022 Financial Results
May 3, 2022
Pacira to Report First Quarter 2022 Financial Results on Wednesday May 4, 2022
April 26, 2022
Pacira BioSciences Reports Preliminary Revenues of $157.4 to $158.4 Million for the First Quarter of 2022
April 11, 2022
Pacira BioSciences to Participate in Fireside Chat at the 21st Annual Needham Virtual Healthcare Conference
April 4, 2022
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $42.6 Million for February 2022
March 14, 2022
Pacira BioSciences to Participate in Fireside Chat at the Barclays Global Healthcare Conference
March 8, 2022
Pacira BioSciences Reports Full-Year and Fourth Quarter 2021 Financial Results
February 23, 2022
Pacira to Report 2021 Financial Results on Thursday February 24, 2022
February 15, 2022
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $37.3 Million for January 2022
February 14, 2022
Pacira Reports Preliminary Unaudited Total Revenue for 2021 of $540.7 Million to $541.7 Million
January 5, 2022
Pacira BioSciences to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 2, 2022
Calls in 2022
- Pacira BioSciences (NASDAQ:PCRX) Q3 2022 Earnings Call
Nov 3, 2022
Transcript - Pacira BioSciences (NASDAQ:PCRX) Q2 2022 Earnings Call
Aug 3, 2022
Transcript - Pacira BioSciences (NASDAQ:PCRX) Q1 2022 Earnings Call
May 4, 2022
Transcript - Pacira BioSciences (NASDAQ:PCRX) Q4 2021 Earnings Call
Feb 24, 2022
Transcript